Angiogenic effect of platelet-rich concentrates on dental pulp stem cells in inflamed microenvironment
- 41 Downloads
In this study, we aimed to determine the suitable concentrations of human platelet lysate (HPL) and platelet-rich plasma (PRP) for maintaining the in vitro proliferative and angiogenic potential of inflamed dental pulp stem cells.
Materials and methods
Lipopolysaccharide (LPS)-induced inflamed dental pulp-derived stem cells (iDPSCs) were treated with different concentrations of HPL and PRP (10% and 20%) followed by determination of viability using Alamar Blue assay. Expression of angiogenesis-, adhesion-, and inflammation-regulating genes was also analyzed using RT-qPCR array. Furthermore, expression of growth factors at protein level in the cell culture microenvironment was measured using multiplex assay.
Viability of iDPSCs was significantly (p < 0.05) higher in 20% HPL-supplemented media compared to iDPSCs. Expression of 10 out of 12 selected angiogenic genes, four out of seven adhesion molecules, and seven out of nine cytokine-producing genes were significantly (p < 0.05) higher in cells maintained in 20% HPL-supplemented media compared to that in FBS-supplemented media. Furthermore, expression of all the selected growth factors was significantly higher (p < 0.05) in the supernatants from 20% HPL media at 12 and 24 h post-incubation.
This study suggests that 20% HPL could be optimum to stimulate angiogenesis-related factors in iDPSCs while maintaining their viability.
This data may suggest the potential use of 20% HPL for expanding DPSCs scheduled for clinical trials for regenerative therapies including dental pulp regeneration.
KeywordsCytokines Growth factors Platelet lysate Platelet-rich plasma Viability
This study was funded by High Impact Research MOHE Grant UM.C/HIR/MOHE/DENT/05 from the Ministry of Higher Education Malaysia.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 1.Berkovitz BK, Holland GR, Moxham BJ (2016) Oral anatomy, histology and embryology. ElsevierGoogle Scholar
- 3.Heyeraas K, Kvinnsland I (1991) Tissue pressure and blood flow in pulpal inflammation. Proc Finn Dent Soc 88:393–401Google Scholar
- 4.Farges J-C (2009) Understanding dental pulp innate immunity - a basis for identifying new targets for therapeutic agents that dampen inflammation. J Appl Oral Sci 17(3), i-iGoogle Scholar
- 7.Yang J, Yuan G, Chen Z (2016) Pulp regeneration: current approaches and future challenges. Front Physiol 7Google Scholar
- 14.Gorin C, Rochefort GY, Bascetin R, Ying H, Lesieur J, Sadoine J, Beckouche N, Berndt S, Novais A, Lesage M, Hosten B, Vercellino L, Merlet P, le-Denmat D, Marchiol C, Letourneur D, Nicoletti A, Vital SO, Poliard A, Salmon B, Muller L, Chaussain C, Germain S (2016) Priming dental pulp stem cells with fibroblast growth factor-2 increases angiogenesis of implanted tissue-engineered constructs through hepatocyte growth factor and vascular endothelial growth factor secretion. Stem Cells Transl Med 5(3):392–404CrossRefGoogle Scholar
- 27.Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, Shapiro RL, Galloway AC, Rifkin DB, Mignatti P (1998) Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol 141(7):1659–1673CrossRefGoogle Scholar
- 30.Sato N, Beitz J, Kato J, Yamamoto M, Clark J, Calabresi P et al (1993) Platelet-derived growth factor indirectly stimulates angiogenesis in vitro. Am J Pathol 142(4):1119Google Scholar
- 43.Fajardo LF, Kwan HH, Kowalski J, Prionas S, Allison A (1992) Dual role of tumor necrosis factor-alpha in angiogenesis. Am J Pathol 140(3):539–544Google Scholar
- 47.Haque N, Abu Kasim NH (2017) Pooled human serum increases regenerative potential of in vitro expanded stem cells from human extracted deciduous teeth. In: Adv Exp Med Biol, https://doi.org/10.1007/5584_2017_74. Springer US, Boston, MA, pp 1–16
- 52.Andia I, Rubio-Azpeitia E (2014) Angiogenic and innate immune responses triggered by PRP in tendon cells are not modified by hyperuricemia. Muscles, ligaments and tendons journal 4(3):292Google Scholar
- 54.Forte D, Ciciarello M, Valerii MC, De Fazio L, Cavazza E, Giordano R et al (2015) Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn’s disease patients in a mouse model of colitis. Stem Cell Res Ther 6(1):170CrossRefGoogle Scholar
- 56.Fortunato, T.M., Beltrami, C., Emanueli, C., De Bank, P.A., Pula, G. (2016). Platelet lysate gel and endothelial progenitors stimulate microvascular network formation in vitro: tissue engineering implications. Sci Rep, 6Google Scholar
- 57.Oliveira SM, Pirraco RP, Marques AP, Santo VE, Gomes ME, Reis RL et al. (2015). Platelet lysate-based pro-angiogenic nanocoatings. Acta BiomaterGoogle Scholar
- 58.Middleton KK, Barro V, Muller B, Terada S, Fu FH (2012) Evaluation of the effects of platelet-rich plasma (PRP) therapy involved in the healing of sports-related soft tissue injuries. The Iowa Orthopaedic Journal 32:150Google Scholar
- 59.Galliera E, Corsi M, Banfi G (2011) Platelet rich plasma therapy: inflammatory molecules involved in tissue healing. J Biol Regul Homeost Agents 26(2 Suppl 1):35S–42SGoogle Scholar